United Arab Emirates Insulin Market Size & Outlook, 2025-2033
United Arab Emirates Insulin Market Insights
- As per Reed Intelligence insights, the United Arab Emirates Insulin Market stood at USD 864.16 Million in 2024 and is anticipated to grow to USD 1070.72 Million by 2033.
- The United Arab Emirates market is expected to advance at a CAGR of 2.41% from 2026 through 2033.
- In 2024, Human Insulin accounted for the highest share of the By Source market size.
- During the forecast period, Human Insulin is set to register the highest growth, making it the most lucrative By Source segment.
![United Arab Emirates Insulin Market Size, Share & Growth Analysis By [2033]](https://reedintelligence.com/uploads/charts/united-arab-emirates-insulin-market-united-arab-emirates-by-source-34726.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2024, United Arab Emirates held 4.32% of the global Insulin Market size.
- By 2033, United States is anticipated to capture the largest share of the global Insulin Market.
- In Middle East and Africa, United Arab Emirates is expected to lead the regional Insulin Market size by 2033.
- Nigeria will remain the fastest-growing market in Middle East and Africa, reaching USD 170.57 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 864.16 Million |
| Market Size In 2033 | USD 1070.72 Million |
| Largest segment | Human Insulin |
| Units | Revenue in USD Million |
| CAGR | 2.41% (2025-2033) |
| Segmnetation Covered | |
| By Source |
|
| By Type |
|
| By Application |
|
| By Delivery System |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Arab Emirates Insulin Market By Source 2025-2033 (USD Million)
| By Source | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human Insulin | XX.x | XX.x | XX.x | 558.33 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Analog Insulin | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Arab Emirates Insulin Market By Type 2025-2033 (USD Million)
| By Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Short Acting Insulin | XX.x | XX.x | XX.x | 353.01 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Intermediate Acting Insulin | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Long-Acting Insulin | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Fast-Acting Insulin | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Arab Emirates Insulin Market By Application 2025-2033 (USD Million)
| By Application | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type II Diabetes, | XX.x | XX.x | XX.x | 346.36 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Type I Diabetes, | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Gestational Diabetes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pre-diabetes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Arab Emirates Insulin Market By Delivery System 2025-2033 (USD Million)
| By Delivery System | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Syringes | XX.x | XX.x | XX.x | 473.65 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pens | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pumps | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
